Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

BGB-58067

Small molecule · Inhibitor of protein arginine methyltransferase 5 (PRMT5) · developed by BeOne Medicines

Phase 1 Most advanced trial
ONC Developer
2 Registered trials

What is BGB-58067?

BGB-58067 is a methylthioadenosine (MTA)-selective small-molecule inhibitor of PRMT5, a type II protein arginine methyltransferase. It binds PRMT5 in the presence of MTA, reducing monomethylated and dimethylated arginine on histone and non-histone proteins, and is designed to act preferentially in MTAP-deleted cancer cells. It is studied in cancer.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Targets
protein arginine methyltransferase 5 (PRMT5), methylthioadenosine phosphorylase (MTAP) (biomarker)
Mechanism
Inhibitor of protein arginine methyltransferase 5 (PRMT5)
Pathways
histone arginine methylation, gene expression regulation of proliferation genes
Therapy area
Oncology
Developer
BeOne Medicines (ONC)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07712640 Phase 1 Healthy Volunteers Recruiting ONC
NCT07590102 Phase 1 Healthy Volunteers Recruiting ONC

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy Volunteers

Other drugs acting on PRMT5

More from BeOne Medicines

Sources

Updated Oct 25, 2026. Something wrong or missing? Report it on the ONC page.

Follow ONC, the company behind BGB-58067

See ONC's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

ONC catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.